Government bans export of anti-malarial drug hydroxycloroquine

Experts had suggested hydroxychloroquine for treating healthcare workers handling coronavirus cases

According to reports, demand for the anti-malarial drug hydroxychloroquine has jumped after there were claims that it is effective in treating COVID-19. Representational image: iStock

Amid the coronavirus outbreak, the government on Wednesday (March 25) banned the export of anti-malarial drug hydroxycloroquine with immediate effect to ensure sufficient availability of the medicine in the domestic market.

Indian Council of Medical Research (ICMR) Director General Balram Bhargava had on Monday (March 23) recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases and also the asymptomatic household contacts of the lab-confirmed cases.

The treatment protocol recommended by the ICMR-constituted National Task Force for COVID-19 has been approved by the Drug Controller General of India (DGCI) for restricted use in emergency situations.

Interactive: Know the coronavirus stats here

In a notification issued on Wednesday, the Directorate General of Foreign Trade (DGFT), an arm of the commerce ministry which deals with export and import-related matters, said, “The export of hydroxycloroquine and formulations made from hydroxycloroquine is prohibited with immediate effect.”

It, however, said the government will allow export of the medicine on humanitarian grounds on case-to-case basis on the Ministry of External Affairs recommendation.

Export will also be permitted from the special economic zones/export-oriented units and in cases where the outbound shipment is made to fulfill export obligation under any advance authorisation license issued on or before the date of this notification, which is March 25, 2020.

Related news | COVID-19: Health ministry gives guidelines for cremation of bodies

It added, “Export will be allowed in case of shipments where irrevocable letter of credit has been issued before the date of this notification or in case where full advance payment has been received by the exporter in India against specific shipment, subject to submission of documentary evidence.”

According to some reports, demand for hydroxychloroquine and chloroquine, a related compound, have jumped after US President Donald Trump said that these salts were effective in treating COVID-19. People are reportedly panic buying this medicine.

Over the last few weeks, India has banned exports of a host of medical devices including sanitisers, all types of ventilators, and surgical masks.

Get breaking news and latest updates from India
and around the world on thefederal.com
FOLLOW US: